NUWE NUWELLIS INC

Nuwellis Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

Nuwellis Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

Video webcast now available on-demand

MINNEAPOLIS, July 23, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., today announced that of Nuwellis, participated in the .

For the event, Mr. Erb dove deeper into his dedication to the Company, how he got to where he is today, and provided insight into why he is passionate about the Company’s programs in development.

The on-demand video webcast is now available on the as well as the  page under the  section of the Company’s website ().

About Nuwellis

Nuwellis, Inc. (Nasdaq: NUWE) is a medical device company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. The company is focused on commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, with a wholly owned subsidiary in Ireland. For more information visit or visit us on LinkedIn or X, formerly known as Twitter.

For further information, please contact:

Investor Relations:

Robert Scott

Chief Financial Officer

Media Contact:

Leah McMullen

Director of Communications



EN
23/07/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NUWELLIS INC

 PRESS RELEASE

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect We...

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech Live video webcast on Thursday, August 21st at 2:40 PM ET MINNEAPOLIS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced that it will present at the being held virtually August 19-21, 2025. Details for the presentation are as follows: Date/Time: Thursday, August 21, 2025 at 2:40 PM ET Presenter: Registration Link: About Webull Financial Webull Finan...

 PRESS RELEASE

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Busin...

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights MINNEAPOLIS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company dedicated to transforming care for fluid overload patients, today announced financial results for the second quarter ended June 30, 2025, and provided a business update. Second Quarter 2025 and Recent Business Highlights Nuwellis continued to advance its strategic realignment during the ...

 PRESS RELEASE

Nuwellis to Exit International Operations to Accelerate U.S. Revenue G...

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus MINNEAPOLIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced its decision to exit international operations in order to focus exclusively on the U.S. market—where the company is seeing the strongest growth and clinical demand. This strategic realignment supports Nuwellis’ core business strategy: investing in the markets driving revenue growth. With expanding tract...

 PRESS RELEASE

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference...

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025 MINNEAPOLIS, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management, today announced that it will postpone its 2025 second quarter earnings release and conference call, originally scheduled for August 12, 2025. The Company requires additional time to complete its valuations and for its audit firm to complete its related audit procedures. There are no current disagreements with Baker Tilly US, LLP, the Company’s auditor. The Compa...

 PRESS RELEASE

Nuwellis Announces the First Successful Outpatient Application of the ...

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code Supported by the recent CMS decision to increase the reimbursement rate, which facilitates broader use of the therapy in outpatient settings MINNEAPOLIS, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming fluid management, today announced that the first patients have been successfully treated with Aquadex® ultrafiltration therapy in a hospital-based outpatient setting. This milestone reflects a major advan...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch